| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.47B | +10.5% |
| Cost of Revenue | $1.07B | -5.9% |
| Gross Profit | $404.6M | +104.6% |
| R&D Expense | $148.6M | -4.6% |
| SG&A Expense | $165.1M | +2.6% |
| Operating Income | $22.9M | +111.0% |
| Interest Expense | $62.6M | -42.2% |
| Pre-tax Income | -$26.4M | +91.4% |
| Income Tax | $846K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $802.9M | +20.8% |
| Accounts Receivable | $335.8M | -1.4% |
| Inventory | $544.7M | +8.4% |
| Current Assets | $2.04B | +20.7% |
| Total Assets | $2.66B | +10.1% |
| Current Liabilities | $636.8M | +35.4% |
| Long-term Debt | $1.13B | +33.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $92.0M | +124.7% |
| Capital Expenditures | $58.9M | -29.7% |
| Investing Cash Flow | -$58.8M | +29.8% |
| Financing Cash Flow | $175.2M | -74.4% |
| Free Cash Flow | $33.1M | +107.3% |
| -55.3% |
| Net Income | -$27.2M | +91.0% |
| EPS (Basic) | -$0.13 | +90.8% |
| EPS (Diluted) | -$0.13 | +90.8% |
| Total Liabilities |
| $2.07B |
| +9.5% |
| Stockholders' Equity | $562.5M | +12.0% |